Venkat Reddy

Venkat Reddy is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as a Board Member at Tavira Therapeutics and Pharmacelera, and as Chief Scientific Officer at General Inception since February 2022. As Co-Founder of Tactile Therapeutics, Venkat Reddy focuses on developing small molecule modulators for Protein Quality Control. Previous roles include CEO and Chief Scientific Officer at Macrophage Pharma, Senior Vice President at Glenmark Pharmaceuticals, and various leadership positions at Pfizer and Sanofi, where Venkat Reddy managed significant biotherapeutic research initiatives and cross-functional teams. With a PhD in Human Biology from Ludwig-Maximilians-Universität München and postdoctoral studies at Scripps Research, Venkat Reddy brings extensive expertise in drug discovery, translational science, and innovation in biotherapeutics.